CHENGDU, Jan. 11 (NBD) -- With private medical service drawing great attention, investment organizations eye high-end health service.

Shenzhen GTJA Investment Group (GTJA) told NBD on Monday, the company reached a strategic cooperation with American-Sino Medical Group to invest 200 million yuan (28.89 million US dollars) in American-Sino Medical Group within this year.

In late 2015, Luye Medical Group acquired Healthe Care Australia with a consideration of 4.4 billion yuan (688 million US dollars at that time).

Wang Wenhua, the executive director with China Insights Consultancy told NBD, high-end medical service institutions, as important parts in the private medical establishment, were driven by the market and capital and achieved rapid expansion over the past few years.

Despite the heated layout of high-end health service institutions by capital inside and outside this industry, many challenges, such as the shortage of doctors, remain to be solved.

Wang said, a high-level medical team constitutes the core competitiveness of a high-end health institution. However, most good doctors work at large public hospitals. Moreover, China's restrictions on doctors' multi-sited license cause inadequate number of high-level doctors in high-end private hospitals or foreign-invested hospitals.

Huang Qing, executive vice president with GTJA said, the number of China's private hospitals achieved a year-on-year growth of 18% in 2016, which presents great development potential in the coming years.

Email: gaohan@nbd.com.cn